The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Abstract
Epilepsy is a common and devastating neurological disorder. In many patients with epilepsy, seizures are well-controlled with currently available anti-epileptic drugs (AEDs), but a substantial (∼30%) proportion of patients continue to have seizures despite carefully optimized drug treatment. Two concepts have been put forward to explain the development of pharmacoresistance. The transporter hypothesis contends that the expression or function of multidrug transporters in the brain is augmented, leading to impaired access of AEDs to CNS targets. The target hypothesis holds that epilepsy-related changes in the properties of the drug targets themselves may result in reduced drug sensitivity. Recent studies have started to dissect the molecular underpinnings of both transporter- and target-mediated mechanisms of pharmacoresistance in human and experimental epilepsy. An emerging understanding of these underlying molecular and cellular mechanisms is likely to provide important impetus for the development of new pharmacological treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Epilepsy: A Comprehensive Textbook
(2008) · JAMA · doi:10.1001/jama.300.4.443-a · Cited by 2,341
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Nomenclature of Voltage-Gated Sodium Channels
Goldin, A. L., Barchi, R. L., Caldwell, J. H., Hofmann, F., Howe, J. R., Hunter, J. C., Kallen, R. G., Mandel, G., Meisler, M. H., Netter, Y. B., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00116-1 · Cited by 1,481
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Hyperpolarization-Activated Cation Currents: From Molecules to Physiological Function
Robinson, R. B., & Siegelbaum, S. A. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142734 · Cited by 1,177
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
On the Origin of Interictal Activity in Human Temporal Lobe Epilepsy in Vitro
Cohen, I., Navarro, V., Clemenceau, S., Baulac, M., & Miles, R. (2002) · Science · doi:10.1126/science.1076510 · Cited by 1,001
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Nomenclature of Voltage-Gated Calcium Channels
Ertel, E. A., Campbell, K. P., Harpold, M. M., Hofmann, F., Mori, Y., Perez-Reyes, E., Schwartz, A., Snutch, T. P., Tanabe, T., Birnbaumer, L., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)81057-0 · Cited by 885
Low-Threshold Calcium Currents in Central Nervous System Neurons
Huguenard, J. R. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001553 · Cited by 763
Brooks-Kayal, A. R., Shumate, M. D., Jin, H., Rikhter, T. Y., & Coulter, D. A. (1998) · Nature Medicine · doi:10.1038/2661 · Cited by 745
Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 665
Study, R. E., & Barker, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7180 · Cited by 561
Pregabalin Pharmacology and Its Relevance to Clinical Practice
Ben‐Menachem, E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.455003.x · Cited by 542
Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., & Piwnica-Worms, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3900 · Cited by 531
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N., Annett, G. M., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 527
Diversity of inhibitory neurotransmission through GABAA receptors
Mody, I., & Pearce, R. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.07.002 · Cited by 525
Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons
Coulter, D. A., Huguenard, J. R., & Prince, D. A. (1989) · Annals of Neurology · doi:10.1002/ana.410250610 · Cited by 504
Sisodiya, S. M., Lin, W. ‐., Harding, B. N., Squier, M. V., & Thom, M. (2002) · Brain · doi:10.1093/brain/awf002 · Cited by 479
GABAA receptor subtypes: dissecting their pharmacological functions
Rudolph, U., Crestani, F., & Möhler, H. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01646-1 · Cited by 471
Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites
Poolos, N. P., Migliore, M., & Johnston, D. (2002) · Nature Neuroscience · doi:10.1038/nn891 · Cited by 454
Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy
Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H., & Johnston, D. (2004) · Science · doi:10.1126/science.1097065 · Cited by 449
Self-citationChen, K., Aradi, I., Thon, N., Eghbal-Ahmadi, M., Baram, T. Z., & Soltesz, I. (2001) · Nature Medicine · doi:10.1038/85480 · Cited by 427
Dombrowski, S. M., Desai, S. Y., Marroni, M., Cucullo, L., Goodrich, K., Bingaman, W., Mayberg, M. R., Bengez, L., & Janigro, D. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.12301.x · Cited by 426
Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
Löscher, W., & Potschka, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.7 · Cited by 409
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
Mody, I., & Heinemann, U. (1987) · Nature · doi:10.1038/326701a0 · Cited by 395
Excitatory Actions of GABA in the Cortex
Gulledge, A. T., & Stuart, G. J. (2003) · Neuron · doi:10.1016/s0896-6273(02)01146-7 · Cited by 388
KCNQ/M Channels Control Spike Afterdepolarization and Burst Generation in Hippocampal Neurons
Yue, C., & Yaari, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0765-04.2004 · Cited by 369
Molecular Basis of an Inherited Epilepsy
Lossin, C., Wang, D. W., Rhodes, T. H., Vanoye, C. G., & George, A. L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00714-6 · Cited by 361
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Gibbs, J. W., Sombati, S., DeLorenzo, R. J., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02164.x · Cited by 348
Tate, S. K., Depondt, C., Sisodiya, S. M., Cavalleri, G. L., Schorge, S., Soranzo, N., Thom, M., Sen, A., Shorvon, S. D., Sander, J. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407346102 · Cited by 345
Selective Blockade of N‐Type Calcium Channels by Levetiracetam
Lukyanetz, E. A., Shkryl, V. M., & Kostyuk, P. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.24501.x · Cited by 338
Differential regulation of γ‐aminobutyric acid receptor channels by diazepam and phenobarbital
Twyman, R. E., Rogers, C. J., & Macdonald, R. L. (1989) · Annals of Neurology · doi:10.1002/ana.410250302 · Cited by 337
Todorovic, S. M., & Lingle, C. J. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.1.240 · Cited by 317
Development of Two Types of Calcium Channels in Cultured Mammalian Hippocampal Neurons
Yaari, Y., Hamon, B., & Lux, H. D. (1987) · Science · doi:10.1126/science.2433765 · Cited by 303
Modulation of KCNQ2/3 Potassium Channels by the Novel Anticonvulsant Retigabine
Main, M. J., Cryan, J. E., Dupere, J. R. B., Cox, B., Clare, J. J., & Burbidge, S. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12060-3 · Cited by 299
Su, H., Sochivko, D., Becker, A., Chen, J., Jiang, Y., Yaari, Y., & Beck, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03645.2002 · Cited by 293
Self-citationSeizure-Induced Plasticity of h Channels in Entorhinal Cortical Layer III Pyramidal Neurons
Shah, M. M., Anderson, A. E., Leung, V., Lin, X., & Johnston, D. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.011 · Cited by 288
Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy
Kwan, P., & Brodie, M. J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.31904.x · Cited by 281
Modulation of High‐Voltage–Activated Calcium Channels in Dentate Granule Cells by Topiramate
Zhang, X., Velumian, A. A., Jones, O. T., & Carlen, P. L. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02173.x · Cited by 276
A novel mechanism underlying drug resistance in chronic epilepsy
Remy, S., Gabriel, S., Urban, B. W., Dietrich, D., Lehmann, T. N., Elger, C. E., Heinemann, U., & Beck, H. (2003) · Annals of Neurology · doi:10.1002/ana.10473 · Cited by 275
Self-citationMcLean, M. J., & Macdonald, R. L. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24966-7 · Cited by 273
Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
Suzuki, S., Kawakami, K., Nishimura, S., Watanabe, Y., Yagi, K., Scino, M., & Miyamoto, K. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90087-a · Cited by 268
Regina, A., Koman, A., Piciotti, M., El Hafny, B., Center, M. S., Bergmann, R., Couraud, P., & Roux, F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020705.x · Cited by 266
Thompson, S. M., & Gahwiler, B. H. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.6.1698 · Cited by 263
Xie, X., Lancaster, B., Peakman, T., & Garthwaite, J. (1995) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00373920 · Cited by 249
Gibbs, J. W., Shumate, M. D., & Coulter, D. A. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.4.1924 · Cited by 248
Rizzi, M., Caccia, S., Guiso, G., Richichi, C., Gorter, J. A., Aronica, E., Aliprandi, M., Bagnati, R., Fanelli, R., D'Incalci, M., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05833.2002 · Cited by 243
Kearney, J. A., Plummer, N. W., Smith, M. R., Kapur, J., Cummins, T. R., Waxman, S. G., Goldin, A. L., & Meisler, M. H. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00479-6 · Cited by 242
Potschka, H., Fedrowitz, M., & Löscher, W. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049858 · Cited by 234
Sanabria, E. R. G., Su, H., & Yaari, Y. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0205g.x · Cited by 230
Willow, M., Gonoi, T., & Catterall, W. A. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12546-7 · Cited by 229
Potschka, H., Fedrowitz, M., & Löscher, W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00423-8 · Cited by 226
Ragsdale, D. S., Scheuer, T., & Catterall, W. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15395-9 · Cited by 226
Sodium channels as molecular targets for antiepileptic drugs
Ragsdale, D. S., & Avoli, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00054-4 · Cited by 221
Gryder, D. S., & Rogawski, M. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07069.2003 · Cited by 216
Block of Cloned Human T-Type Calcium Channels by Succinimide Antiepileptic Drugs
Gomora, J. C., Daud, A. N., Weiergräber, M., & Perez-Reyes, E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12522-9 · Cited by 216
Rogers, C. J., Twyman, R. E., & Macdonald, R. L. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020050 · Cited by 215
Kuo, C.-C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13073-8 · Cited by 212
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy
Tan, N. C. K., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C., & Berkovic, S. F. (2004) · Neurology · doi:10.1212/01.wnl.0000137051.33486.c7 · Cited by 211
Su, H., Alroy, G., Kirson, E. D., & Yaari, Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04173.2001 · Cited by 208
Batrakova, E. V., Li, S., Miller, D. W., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018990706838 · Cited by 206
ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
Kerb, R., Hoffmeyer, S., & Brinkmann, U. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.51 · Cited by 202
Gabapentin inhibits calcium currents in isolated rat brain neurons
Stefani, A., Spadoni, F., & Bernardi, G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(97)00189-5 · Cited by 201
Potschka, H., Fedrowitz, M., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00037 · Cited by 201
Expression of Multidrug Resistance-Associated Protein (MRP) in Brain Microvessel Endothelial Cells
Huai-Yun, H., Secrest, D. T., Mark, K. S., Carney, D., Brandquist, C., Elmquist, W. F., & Miller, D. W. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8132 · Cited by 199
Bender, R. A., Soleymani, S. V., Brewster, A. L., Nguyen, S. T., Beck, H., Mathern, G. W., & Baram, T. Z. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06826.2003 · Cited by 199
Self-citationAronica, E., Gorter, J. A., Jansen, G. H., van Veelen, C. W. M., van Rijen, P. C., Leenstra, S., Ramkema, M., Scheffer, G. L., Scheper, R. J., & Troost, D. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00992-2 · Cited by 197
GABA and Its Receptors in Epilepsy
Sperk, G., Furtinger, S., Schwarzer, C., & Pirker, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-6376-8_7 · Cited by 193
On the Action of the Anti-Absence Drug Ethosuximide in the Rat and Cat Thalamus
Leresche, N., Parri, H. R., Erdemli, G., Guyon, A., Turner, J. P., Williams, S. R., Asprodini, E., & Crunelli, V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04842.1998 · Cited by 187
Diversity of Mammalian Voltage‐Gated Sodium Channels
GOLDIN, A. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11272.x · Cited by 186
Fink-Jensen, A., Suzdak, P. D., Swedberg, M. D. B., Judge, M. E., Hansen, L., & Nielsen, P. G. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90748-s · Cited by 185
Inhibition of Transient and Persistent Na+ Current Fractions by the New Anticonvulsant Topiramate
Taverna, S., Sancini, G., Mantegazza, M., Franceschetti, S., & Avanzini, G. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38047-4 · Cited by 184
Potschka, H., & Löscher, W. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.01901.x · Cited by 181
Increased NMDA responses and dendritic degeneration in human epileptic hippocampal neurons in slices
Isokawa, M., & Levesque, M. F. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90304-c · Cited by 176
Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy
Rhodes, T. H., Lossin, C., Vanoye, C. G., Wang, D. W., & George, A. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402482101 · Cited by 175
Herrero, A. I., Del Olmo, N., González-Escalada, J. R., & Solı́s, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00171-x · Cited by 174
Volk, H. A., & Löscher, W. (2005) · Brain · doi:10.1093/brain/awh437 · Cited by 170
Fink, K., Meder, W., Dooley, D. J., & Göthert, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703380 · Cited by 169
Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats
Kohr, G., De Koninck, Y., & Mody, I. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03612.1993 · Cited by 168
Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall, W. A. (1999) · PubMed · Cited by 167
Hippocampal GABAAchannel conductance increased by diazepam
Eghbali, M., Curmi, J. P., Birnir, B., & Gage, P. W. (1997) · Nature · doi:10.1038/40404 · Cited by 162
Spampanato, J., Kearney, J. A., de Haan, G., McEwen, D. P., Escayg, A., Aradi, I., MacDonald, B. T., Levin, S. I., Soltesz, I., Benna, P., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2034-04.2004 · Cited by 159
Decl�ves, X., Regina, A., Laplanche, J.-L., Roux, F., Boval, B., Launay, J.-M., & Scherrmann, J.-M. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000601)60:5<594::aid-jnr4>3.0.co;2-6 · Cited by 158
GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors
Dalby, N. O. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00075-7 · Cited by 157
Wu, Y., Wang, W., & Richerson, G. B. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00856.2002 · Cited by 155
Significance of MDR1 and multiple drug resistance in refractory human epileptic brain
Marchi, N., Hallene, K. L., Kight, K. M., Cucullo, L., Möddel, G., Bingaman, W. E., Dini, G., Vezzani, A., & Janigro, D. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-37 · Cited by 150
Levetiracetam does not modulate neuronal voltage-gated Na and T-type Ca currents
Zona, C., Niespodziany, I., Marchetti, C., Klitgaard, H., Bernardi, G., & Margineanu, D. G. (2001) · Seizure · doi:10.1053/seiz.2000.0504 · Cited by 149
Madeja, M., Margineanu, D. G., Gorji, A., Siep, E., Boerrigter, P., Klitgaard, H., & Speckmann, E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00248-x · Cited by 149
Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats
Leite, J. P., & Cavalheiro, É. A. (1995) · Epilepsy Research · doi:10.1016/0920-1211(94)00070-d · Cited by 148
Carbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 146
Oxcarbazepine: Mechanisms of Action
McLean, M. J., Schmutz, M., Wamil, A. W., et al. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05949.x · Cited by 144
Brain Microvascular and Astrocyte Localization of P‐Glycoprotein
Pardridge, W. M., Golden, P. L., Kang, Y., & Bickel, U. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031278.x · Cited by 144
FROM GABAA RECEPTOR DIVERSITY EMERGES A UNIFIED VISION OF GABAergic INHIBITION
Costa, E. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.321 · Cited by 143
A single-nucleotide polymorphism tagging set for human drug metabolism and transport
Ahmadi, K. R., Weale, M. E., Xue, Z., Soranzo, N., Yarnall, D. P., Briley, J. D., Maruyama, Y., Kobayashi, M., Wood, N. W., Spurr, N. K., et al. (2004) · Nature Genetics · doi:10.1038/ng1488 · Cited by 142
Schwarz, J. R., & Grigat, G. (1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05300.x · Cited by 141
Stefani, A., Spadoni, F., & Bernardi, G. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6554 · Cited by 141
Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy?
Stefani, A., Spadoni, F., & Bernardi, G. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01477.x · Cited by 138
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels
Kerb, R., Aynacioglu, A. S., Brockmöller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgärtner, C., Ongen, H. Z., et al. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500025 · Cited by 135
Cohen, A. S., Lin, D. D., Quirk, G. L., & Coulter, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02597.x · Cited by 133
Ellerkmann, R. K., Remy, S., Chen, J., Гарриевич, С. Д., Elger, C. E., Urban, B. W., Becker, A. J., & Beck, H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00168-4 · Cited by 132
Self-citationGabapentin Increases the Hyperpolarization‐activated Cation Current Ih in Rat CA1 Pyramidal Cells
Surges, R., Freiman, T. M., & Feuerstein, T. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.36802.x · Cited by 130
Schumacher, T. B., Beck, H., Steinhäuser, C., Schramm, J., & Elger, C. E. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01387.x · Cited by 129
Self-citationSegal, M. M., & Douglas, A. F. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.6.3021 · Cited by 128
Volk, H. A., Burkhardt, K., Potschka, H., Chen, J., Becker, A. J., & Löscher, W. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.012 · Cited by 125
Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
Wang, S., Huang, C., Hsu, K., Tsai, J.-J., & Gean, P. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00048 · Cited by 121
Voltage‐gated Sodium Channels in Epilepsy
Köhling, R. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.40501.x · Cited by 118
Soranzo, N., Gl, C., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., & Goldstein, D. B. (2004) · Genome Research · doi:10.1101/gr.1965304 · Cited by 118
Over-expression of Pglycoprotein in malformations of cortical development
Sisodiya, S. M., Heffernan, J. M., & Squier, M. V. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00032 · Cited by 115
Kindling enhances sensitivity of CA3 hippocampal pyramidal cells to NMDA
Martin, D., McNamara, J., & Nadler, J. V. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01928.1992 · Cited by 114
Stefani, A., Pisani, A., Murtas, M. D., Mercuri, N. B., Marciani, M. G., & Calabresi, P. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00958.x · Cited by 111
ffrench-Mullen, J. M. H., Barker, J. L., & Rogawski, M. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03211.1993 · Cited by 110
Todorovic, S. M., Perez‐Reyes, E., & Lingle, C. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.98 · Cited by 104
Vreugdenhil, M., & Wadman, W. J. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02034.x · Cited by 103
Cavalleri, G. L., Lynch, J. M., Depondt, C., Burley, M., Wood, N. W., Sisodiya, S. M., & Goldstein, D. B. (2005) · Brain · doi:10.1093/brain/awh524 · Cited by 100
Brooks‐Kayal, A. R., Shumate, M. D., Jin, H., Lin, D. D., Rikhter, T. Y., Holloway, K. L., & Coulter, D. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08312.1999 · Cited by 100
P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries
Golden, P. L., & Pardridge, W. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01305-5 · Cited by 98
Zhang, L., Ong, W.-Y., & Lee, T. (1999) · Experimental Brain Research · doi:10.1007/s002210050759 · Cited by 97
McClelland, D. E., Evans, R. M., Barkworth, L., Martin, D. J., & Scott, R. H. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-14 · Cited by 97
A crossover, add-on trial of talampanel in patients with refractory partial seizures
Chappell, A. S., Sander, J. W. A. S., Brodie, M. J., Chadwick, D., Lledó, A., Zhang, D., Bjerke, J. S., Kiesler, G. M., & Arroyo, S. (2002) · Neurology · doi:10.1212/wnl.58.11.1680 · Cited by 95
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
Sills, G. J., Kwan, P., Butler, E., de Lange, E. C. M., van den Berg, D., & Brodie, M. J. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00511-5 · Cited by 95
Lindstr�m, S., & Wr�bel, A. (1990) · Experimental Brain Research · doi:10.1007/bf00608240 · Cited by 92
Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons
Taverna, S., Mantegazza, M., Franceschetti, S., & AVANZINI, G. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00060-6 · Cited by 90
Felbamate block of recombinant N-methyl-d-aspartate receptors: selectivity for the NR2B subunit
Harty, T. P., & Rogawski, M. A. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00108-4 · Cited by 90
Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones
Chao, T. I., & Alzheimer, C. (1995) · Neuroreport · doi:10.1097/00001756-199509000-00017 · Cited by 87
Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam, S., Rho, J. M., Penix, L. P., Donevan, S. D., Fielding, R. P., & Rogawski, M. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09605-3 · Cited by 85
Felbamate modulates the strychnine-insensitive glycine receptor
White, H. S., Harmsworth, W. L., Sofia, R. D., & Wolf, H. H. (1995) · Epilepsy Research · doi:10.1016/0920-1211(94)00066-6 · Cited by 83
Barbiturate-Like Actions of the Propanediol Dicarbamates Felbamate and Meprobamate
Rho, J. M., Donevan, S. D., & Rogawski, M. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36535-8 · Cited by 82
Kleckner, N. W., Glazewski, J. C., Chen, C. C., & Moscrip, T. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38215-1 · Cited by 81
Differential Effect of Gabapentin on Neuronal and Muscle Calcium Currents
Alden, K. J., & Garcı́a, J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29591-4 · Cited by 81
Aronica, E., Yankaya, B., Troost, D., van Vliet, E. A., Lopes, F. H. D. S., & Gorter, J. A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01502.x · Cited by 79
Bartoloméi, F., Gastaldi, M., Massacrier, A., Planells, R., Nicolas, S., & Cau, P. (1997) · Journal of Neurocytology · doi:10.1023/a:1018549928277 · Cited by 77
Whitaker, W. R. J., Faull, R. L. M., Dragunow, M., Mee, E. T., Emson, P. C., & Clare, J. J. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00212-3 · Cited by 77
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons
Spadoni, F., Hainsworth, A. H., Mercuri, N. B., Caputi, L., Martella, G., Lavaroni, F., Bernardi, G., & Stefani, A. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00019 · Cited by 77
L�scher, W., & H�rstermann, D. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169293 · Cited by 74
Zona, C., & Avoli, M. (1990) · Experimental Brain Research · doi:10.1007/bf00228121 · Cited by 73
Brain Microvascular P-Glycoprotein and a Revised Model of Multidrug Resistance in Brain
Golden, P. L., & Pardridge, W. M. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007093521681 · Cited by 72
Vreugdenhil, M., van Veelen, C. W. M., van Rijen, P. C., Lopes, F. H. D. S., & Wadman, W. J. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00061-8 · Cited by 72
Xie, X., Dale, T. J., John, V. H., Cater, H. L., Peakman, T. C., & Clare, J. J. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000448 · Cited by 71
Pentobarbital and picrotoxin have reciprocal actions on single GABAA receptor channels
Twyman, R. E., Rogers, C. J., & Macdonald, R. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90248-6 · Cited by 71
Lucas, P. T., Meadows, L. S., Nicholls, J., & Ragsdale, D. S. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.03.003 · Cited by 68
Lampl, I., Schwindt, P. C., & Crill, W. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37226-x · Cited by 64
Potschka, H., Fedrowitz, M., & Löscher, W. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.22603.x · Cited by 63
Gastaldi, M., Bartoloméi, F., Massacrier, A., Planells, R., Robaglia‐Schlupp, A., & Cau, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00199-4 · Cited by 63
Neocortical Potassium Currents Are Enhanced by the Antiepileptic Drug Lamotrigine
Zona, C., Tancredi, V., Longone, P., D’Arcangelo, G., D’Antuono, M., Manfredi, M., & Avoli, M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.51401.x · Cited by 63
Block of T -Type Ca2+ Channels Is an Important Action of Succinimide Antiabsence Drugs
Huguenard, J. R. (2002) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2002.00019.x · Cited by 61
Block of T-Type Ca 2+ Channels Is an Important Action of Succinimide Antiabsence Drugs
Huguenard, J. R. (2002) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2002.00019.x · Cited by 59
Gordey, M., DeLorey, T. M., & Olsen, R. W. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02167.x · Cited by 58
Topiramate alters excitatory synaptic transmission in mouse hippocampus
Qian, J., & Noebels, J. L. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00120-7 · Cited by 56
Freiman, T. M., Kukolja, J., Heinemeyer, J., et al. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100408 · Cited by 54
Fate of Newborn Dentate Granule Cells after Early Life Status Epilepticus
Porter, B. E., Maronski, M., & Brooks‐Kayal, A. R. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2004.23903.x · Cited by 49
Kwan, P., Sills, G. J., Butler, E., Gant, T. W., Meldrum, B. S., & Brodie, M. J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.156702.x · Cited by 48
Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain
Taglialatela, M., Ongini, E., Brown, A. M., Renzo, G. D., & Annunziato, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00802-3 · Cited by 43
Huang, C., Huang, C., Liu, Y., & Wu, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.58403.x · Cited by 41
Kuo, C., Lin, B., Chang, H.-R., & Hsieh, C.-P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.370 · Cited by 40
Is the persistent sodium current a specific target of anti-absence drugs?
Niespodziany, I., Klitgaard, H., & Margineanu, D. G. (2004) · Neuroreport · doi:10.1097/00001756-200404290-00023 · Cited by 39
The antiepileptic drug losigamone decreases the persistent Na+ current in rat hippocampal neurons
Gebhardt, C., Breustedt, J., Nöldner, M., Chatterjee, S. S., & Heinemann, U. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02863-3 · Cited by 34
Curia, G., Aracri, P., Sancini, G., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.040 · Cited by 29
Functional expression of human P‐glycoprotein in Schizosaccharomyces pombe
Ueda, K., Shimabuku, A. M., Konishi, H., Fujii, Y., Takebe, S., Nishi, K., Yoshida, M., Beppu, T., & Komano, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80888-2 · Cited by 29
van Vliet, E. A., Aronica, E., Redeker, S., & Gorter, J. A. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.23504.x · Cited by 25
A discriminant block among K+ channel types by phenytoin in neuroblastoma cells
Nobile, M., & Lagostena, L. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702035 · Cited by 20
Cited by
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853
Kwan, P., Schachter, S. C., & Brodie, M. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004418 · Cited by 1,052
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Metadata
- Authors
- Remy, S., & Beck, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-29
- Volume
- 129
- Issue
- 1
- Pages
- 18-35
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2126829625
- Cited by
- 406
- References
- 168
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.